Cogent Biosciences's three largest insider shareholders as of June 09, 2026 are Andrew R Robbins (President And Ceo, 657.50K shares), Cole Pinnow (Chief Commercial Officer, 216.65K shares), John Edward Robinson (Chief Scientific Officer, 140.00K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Andrew R Robbins | President And Ceo | 657,503 | 0 | 19 Dec, 2025 |
| Evan Kearns | Chief Legal Officer | 109,398 | 0 | 30 Dec, 2025 |
| John Edward Robinson | Chief Scientific Officer | 140,002 | 0 | 30 Dec, 2025 |
| Cole Pinnow | Chief Commercial Officer | 216,650 | 0 | 19 Dec, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 01 Apr, 2026 | Karen Jean Ferrante | Stock Option (Right to Buy) | A | 686 | $0.00 | 686 | D | A |
| 01 Jan, 2026 | Karen Jean Ferrante | Stock Option (Right to Buy) | A | 643 | $0.00 | 643 | D | A |
| 26 Dec, 2025 | John Edward Robinson | Common Stock | D | 90,000 | $38.74 | 140,002 | D | S |
| 26 Dec, 2025 | Evan Kearns | Common Stock | D | 65,000 | $38.70 | 109,398 | D | S |
| 26 Dec, 2025 | Evan Kearns | Common Stock | D | 65,000 | $38.70 | 109,398 | D | S |
| 26 Dec, 2025 | John Edward Robinson | Common Stock | D | 90,000 | $38.74 | 140,002 | D | S |
| 17 Dec, 2025 | Andrew R Robbins | Common Stock | A | 185,000 | $0.00 | 185,000 | D | A |
| 17 Dec, 2025 | John Edward Robinson | Common Stock | A | 50,000 | $0.00 | 50,000 | D | A |
| 17 Dec, 2025 | Cole Pinnow | Common Stock | A | 50,000 | $0.00 | 97,450 | D | A |
| 17 Dec, 2025 | Cole Pinnow | Common Stock | A | 50,000 | $0.00 | 97,450 | D | A |
| 17 Dec, 2025 | Evan Kearns | Common Stock | A | 40,000 | $0.00 | 40,000 | D | A |
| 17 Dec, 2025 | John Edward Robinson | Common Stock | A | 50,000 | $0.00 | 50,000 | D | A |
| 17 Dec, 2025 | Evan Kearns | Common Stock | A | 40,000 | $0.00 | 40,000 | D | A |
| 17 Dec, 2025 | Andrew R Robbins | Common Stock | A | 185,000 | $0.00 | 185,000 | D | A |
| 17 Dec, 2025 | Andrew R Robbins | Common Stock | A | 840,000 | $0.00 | 1,025,000 | D | A |
| 17 Dec, 2025 | John Edward Robinson | Common Stock | A | 320,000 | $0.00 | 370,000 | D | A |
| 17 Dec, 2025 | Cole Pinnow | Common Stock | A | 214,000 | $0.00 | 311,450 | D | A |
| 17 Dec, 2025 | Evan Kearns | Common Stock | A | 260,000 | $0.00 | 300,000 | D | A |
| 17 Dec, 2025 | Evan Kearns | Common Stock | A | 260,000 | $0.00 | 300,000 | D | A |
| 17 Dec, 2025 | Cole Pinnow | Common Stock | A | 214,000 | $0.00 | 311,450 | D | A |